Orthorexia Nervosa in Postmenopausal Osteoporosis

NCT06947213 | Recruiting

• 1 other identifier: Beylikdüzüstateh17
• Study Type: observational
• Target: 128
• Locations: 1 country
• Sites: 1

Brief Summary

A total of 64 female patients diagnosed with osteoporosis based on dual-energy X-ray absorptiometry (DXA) measurements performed within the last six months, and 64 age-matched healthy controls without osteoporosis, will be included in our study. Sociodemographic data such as age, sex, height, weight, and BMI will be recorded. Additionally, information regarding the duration of osteoporosis diagnosis, current treatments, history of fractures, history of falls, comorbidities, and smoking status will be collected. Femoral neck and L1-L4 T-scores and bone mineral density values obtained from existing DXA scans will be documented. Orthorexia nervosa-related symptoms will be assessed using the ORTO-11 scale, mood will be evaluated using the Hospital Anxiety and Depression Scale (HADS), and body image will be assessed using the Body Appreciation Scale-2.

Conditions

Osteoporosis

Outcome Measures

Primary Outcomes (1)

• ORTO-11 Scale

  The ORTO-11 assesses orthorexic tendencies, which refer to an unhealthy obsession with healthy eating. It consists of 11 items rated on a 4-point Likert scale. Total scores range from 11 to 44, with lower scores indicating a higher risk of orthorexia nervosa.

  Baseline

Secondary Outcomes (1)

• Body Appreciation Scale-2 (BAS-2)

  Baseline

Other Outcomes (2)

• Hospital Anxiety and Depression Scale (HADS)- Anxiety Score

  Baseline

• Hospital Anxiety and Depression Scale (HADS)- Depression Score

  Baseline

Eligibility Criteria

• Age: 55 Years - 75 Years
• Sex: female
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

The study population will consist of postmenopausal women with osteoporosis and age-matched healthy controls

You may qualify if:

• Women between 55-75 years
• Women diagnosed with osteoporosis based on DXA measurements performed within the past six months.
• Women aged similarly to the osteoporosis group without a diagnosis of osteoporosis (healthy controls).
• Willingness to participate and provision of written informed consent.

You may not qualify if:

• Refusal to participate in the study.
• Diagnosed psychiatric disorders.
• Cognitive impairment.
• Presence of malignancy.
• Presence of endocrine disorders (e.g., hyperthyroidism, Cushing's syndrome).
• Use of glucocorticoids.
• Use of medications affecting mood.

Sponsors & Collaborators

• Beylikduzu State Hospital: lead

Study Sites (1)

Beylikdüzü State Hospital

Istanbul, 34147, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Osteoporosis

Condition Hierarchy (Ancestors)

Bone Diseases, Metabolic; Bone Diseases; Musculoskeletal Diseases; Metabolic Diseases; Nutritional and Metabolic Diseases

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: CROSS SECTIONAL
• Target Duration: 1 Day
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principle Investigator

Study Record Dates

• First Submitted: April 20, 2025
• First Posted: April 27, 2025
• Study Start: April 20, 2025
• Primary Completion: May 20, 2025
• Study Completion: May 20, 2025
• Last Updated: April 27, 2025

Record last verified: 2025-04

Locations

TU (1)